HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaojuan Wei Selected Research

Immunotherapy

10/2014Antiviral efficacy analysis of telbivudine concurrent with the first cycle of chemotherapy in HBsAg-positive lymphoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaojuan Wei Research Topics

Disease

7Neoplasms (Cancer)
09/2023 - 08/2016
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 08/2016
3Infections
01/2021 - 02/2014
3Lymphoma (Lymphomas)
11/2020 - 10/2014
3Wounds and Injuries (Trauma)
10/2020 - 08/2013
2Adenocarcinoma of Lung
03/2024 - 05/2023
2Myocardial Ischemia (Ischemic Heart Diseases)
07/2023 - 06/2023
2Reperfusion Injury
07/2023 - 06/2023
2Myocardial Infarction
01/2022 - 04/2019
2Hypoxia (Hypoxemia)
01/2022 - 01/2016
2Disease Progression
11/2020 - 03/2019
2Body Weight (Weight, Body)
01/2020 - 01/2019
1Stomach Neoplasms (Stomach Cancer)
02/2024
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2023
1Ataxia Telangiectasia (Louis Bar Syndrome)
09/2023
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2023
1Heart Injuries
01/2022
1Neoplasm Metastasis (Metastasis)
01/2021
1Inflammation (Inflammations)
01/2021
1Coccidiosis
01/2021
1Diabetes Mellitus
01/2020
1Poisoning
10/2019
1Fascioliasis
04/2019
1Mycoses (Diseases, Fungus)
03/2019
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2018
1Bone Marrow Diseases (Bone Marrow Disease)
10/2014

Drug/Important Bio-Agent (IBA)

3Therapeutic UsesIBA
01/2022 - 04/2019
2Circulating Tumor DNAIBA
09/2023 - 11/2020
2Lysine (L-Lysine)FDA Link
07/2023 - 06/2023
2HydrogelsIBA
01/2022 - 04/2019
2CollagenIBA
01/2021 - 10/2020
2ibrutinibIBA
11/2020 - 03/2019
2OxyclozanideIBA
04/2019 - 01/2019
2AlginatesIBA
02/2014 - 08/2013
1Bevacizumab (Avastin)FDA Link
03/2024
1Immune Checkpoint InhibitorsIBA
03/2024
1polyene phosphatidylcholineIBA
02/2024
1Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2024
1STAT6 Transcription FactorIBA
09/2023
1Neurofibromin 1 (Neurofibromin)IBA
09/2023
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2023
1F-Box ProteinsIBA
09/2023
1DioxygenasesIBA
09/2023
1Adaptor Protein Complex 3IBA
09/2023
1Cyclin-Dependent Kinase Inhibitor p15IBA
09/2023
1Epithelial Cell Adhesion MoleculeIBA
09/2023
1STAT5 Transcription FactorIBA
09/2023
1Janus Kinase 1IBA
09/2023
1MicroRNAs (MicroRNA)IBA
06/2023
1Peptides (Polypeptides)IBA
01/2022
1Matrix Metalloproteinases (MMPs)IBA
01/2022
1fucoidanIBA
01/2021
1Cadherins (E-Cadherin)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1Cell Adhesion MoleculesIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Aloe vera gelIBA
01/2021
1PowdersIBA
01/2021
1Ethanol (Ethyl Alcohol)IBA
01/2021
1Methotrexate (Mexate)FDA LinkGeneric
11/2020
1SolutionsIBA
01/2020
1Circular RNAIBA
01/2020
1AlkaloidsIBA
10/2019
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
04/2019
1SuspensionsIBA
04/2019
1salicylanilideIBA
04/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1CarcinogensIBA
01/2018
1Anaplastic Lymphoma KinaseIBA
01/2018
1CrizotinibIBA
01/2018
1NF-kappa B (NF-kB)IBA
01/2017
1Recombinant ProteinsIBA
01/2017
1Angiopoietin-Like Protein 2IBA
01/2017
1HLA-G Antigens (HLA G)IBA
08/2016
1Annexin A5IBA
01/2016
1Small Interfering RNA (siRNA)IBA
01/2016
1PhosphatidylserinesIBA
01/2016
1AntibodiesIBA
01/2016
1Rituximab (Mabthera)FDA Link
10/2014
1Antiviral Agents (Antivirals)IBA
10/2014
1Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2014
1Hepatitis B e AntigensIBA
10/2014
1TelbivudineFDA Link
10/2014

Therapy/Procedure

4Drug Therapy (Chemotherapy)
03/2024 - 10/2014
3Therapeutics
03/2024 - 11/2020
1Injections
01/2022
1Ventriculoperitoneal Shunt
07/2019
1Artificial Skin
11/2016
1Immunotherapy
10/2014